Prevail Therapeutics Inc. announced earnings results for the Year ended December 31, 2019. For the year, the company reported total operating loss $65,803,000 against $18,809,000 a year ago. Net loss was $63,188,000 against $19,087,000 a year ago. Net loss per basic and diluted share was $2.22 against $3.71 a year ago.